A new concept for an old system: The anti-inflammatory paradigm of the renin-angiotensin system

Medical Hypotheses

Volumn 72, Issue 5, 2009, Pages 584-588

  Serrano, German L ^a   Ritchie, Bob ^a   Hoffman, Daniel ^a   Ferder, Leon ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SODIUM; WATER;

ANTIINFLAMMATORY ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR DISEASE; CYTOPLASM; DRUG MECHANISM; HUMAN; MITOCHONDRION; MOLECULAR EVOLUTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANTIHYPERTENSIVE AGENTS; HUMANS; OXIDATIVE STRESS; RENIN-ANGIOTENSIN SYSTEM; SUBCELLULAR FRACTIONS;

EID: 60849099017     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.11.036     Document Type: Article

References (28)

1. Basso N. Historia del descubrimiento de la angiotensina. Breve reseña. Bol Cons Argent Hiperten Art 2 2 (2001) 10-18
2. Erdös E.G. The ACE and I: how ACE inhibitors came to be. FASEB J 20 8 (2006) 1034-1038
3. Cushman D.W., and Ondetti M.A. History of the design of captopril and related inhibitors of angiotensin converting enzyme. Hypertension 17 4 (1991) 589-592
4. Ferreira S.H. A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. Br J Pharmacol Chemother 24 (1965) 163-169
5. Bakhle Y.S. Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature 220 5170 (1968) 919-921
6. Kuhn T. The structure of scientific revolutions (1962), University of Chicago Press, Chicago, IL
7. Nishimura H. Angiotensin receptors - evolutionary overview and perspectives. Comp Biochem Physiol A Mol Integr Physiol 128 1 (2001) 11-30
8. Smith H. From fish to philosopher (1953), Little, Brown and Company, Boston, MA
9. Bernard C. An introduction to the study of experimental medicine (1957), Dover Publications, New York, NY
10. de Cavanagh E.M.V., Inserra F., Ferder M., and Ferder L. From mitochondria to disease: role of the renin-angiotensin system. Am J Nephrol 27 6 (2007) 545-553
11. Ferder L., Inserra F., and Martínez-Maldonado M. Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress. Curr Hypertens Rep 8 3 (2006) 191-198
12. Ferder L., Inserra F., and Basso N. Advances in our understanding of aging: role of the renin-angiotensin system. Curr Opin Pharmacol 2 2 (2002) 189-194
13. Bachelard G. El Nuevo espíritu científico. Sánchez R, trans. Mexico City, Mexico: Editorial Nueva Imagen; 1981.
14. Bachelard G. La Formación del espíritu científico. Babini J, trans. Buenos Aires, Argentina: Editorial Siglo XXI; 1938.
15. Pattacini L., Casali B., Boiardi L., Pipitone N., Albertazzi L., and Salvarani C. Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the At1-NF-kB pathway. Rheumatology (Oxford) 46 8 (2007) 1252-1257
16. Price A., Lockhart J.C., Ferrell W.R., Gsell W., McLean S., and Sturrock R.D. Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis. Arthritis Rheum 56 2 (2007) 441-447
17. Wang J., Ho L., Chen L., et al. Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 117 11 (2007) 3393-3402
18. Zimman O.A., Toblli J., Stella I., Ferder M., Ferder L., and Inserra F. The effects of angiotensin-converting-enzyme inhibitors on the fibrous envelope around mammary implants. Plast Reconstr Surg 120 7 (2007) 2025-2033
19. Haddad G., Amiri F., and Garcia R. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism. Regul Peptides 68 2 (1997) 111-117
20. Heymes C., Silvestre J.S., Llorens-Cortes C., et al. Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes. Endocrinology 139 5 (1998) 2579-2587
21. Sechi L.A., Griffin C.A., Giacchetti G., et al. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension 28 3 (1996) 403-408
22. de Cavanagh EMV, Flores I, Ferder M, Inserra F, Ferder L. Renin-angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial CNA content and gene expression. Exp Gerontol 2008:43(10):919-28. Epub 2008 August 15.
23. Inserra F, Userpater M, Ferder M, Ferder L. Thiazide Diuretics do not protect against the changes that accompany any renal aging, accepted for publication.
24. Vaziri N.D., Bai Y., Ni Z., Quiroz Y., Pandian R., and Rodriguez-Iturbe B. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 323 1 (2007) 85-93
25. Mueller C.F., and Nickenig G. Angiotensin II: one driving force behind atherogenesis. Hypertension 51 2 (2008) 175-176
26. Wissler R.W., and Strong J.P. PDAY research group. Risk factors and progression of atherosclerosis in youth. Am J Pathol 153 4 (1998) 1023-1033
27. Gansevoort R.T., de Zeeuw D., and de Jong P.E. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?. Kidney Int 45 3 (1994) 861-867
28. Skilton M.R. Intrauterine risk factors for precocious atherosclerosis. Pediatrics 121 3 (2008) 570-574